IQVIA Holdings Inc (IQV, Financial)(30-Year Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2019. IQVIA Holdings Inc is an information and technology-enabled healthcare service provider to the pharmaceutical services, biotechnology, and healthcare industries. The Commercial Solutions and Research and Development Solutions generate maximum revenue. IQVIA Holdings Inc has a market cap of $31.6 billion; its shares were traded at around $164.35 with a P/E ratio of 169.44 and P/S ratio of 2.96. IQVIA Holdings Inc had annual average EBITDA growth of 13.50% over the past five years. GuruFocus has detected 3 severe warning signs with IQVIA Holdings Inc. .
For the last quarter IQVIA Holdings Inc reported a revenue of $2.9 billion, compared with the revenue of $2.7 billion during the same period a year ago. For the latest fiscal year the company reported a revenue of $11.1 billion, an increase of 6.5% from last year. For the complete 30-year financial data, please go here.. For the last five years IQVIA Holdings Inc had an average revenue growth rate of 17.6% a year.
The reported diluted earnings per share was 96 cents for the year, a decline of 22.6% from the previous year. Over the last five years IQVIA Holdings Inc had an average EPS decline of 14.4% a year. The IQVIA Holdings Inc had an operating margin of 7.68%, compared with the operating margin of 7.77% a year before. The 10-year historical median operating margin of IQVIA Holdings Inc is 9.06%. The profitability rank of the company is 8 (out of 10).
At the end of the fiscal year, IQVIA Holdings Inc has the cash and cash equivalents of $837.0 million, compared with $891.0 million in the previous year. The long term debt was $11.9 billion, compared with $10.9 billion in the previous year. The interest coverage to the debt is 1.9, which is not a favorable level. IQVIA Holdings Inc has a financial strength rank of 3 (out of 10).
At the current stock price of $164.35, IQVIA Holdings Inc is traded at 79.2% premium to its historical median P/S valuation band of $91.69. The P/S ratio of the stock is 2.96, while the historical median P/S ratio is 1.65. The stock gained 16.43% during the past 12 months.
Directors and Officers Recent Trades:
- Director Michael J Evanisko sold 6,250 shares of IQV stock on 01/31/2020 at the average price of $155.19. The price of the stock has increased by 5.9% since.
- Director Michael J Evanisko sold 6,250 shares of IQV stock on 01/24/2020 at the average price of $159.07. The price of the stock has increased by 3.32% since.
For the complete 20-year historical financial data of IQV, click here.
